Human medicines European public assessment report EPAR Idacio adalimumab Arthritis RheumatoidArthritis Juvenile RheumatoidPsoriasisArthritis PsoriaticSpondylitis AnkylosingUveitisHidradenitis SuppurativaColitis UlcerativeCrohn Disease D

Human medicines European public assessment report EPAR Idacio adalimumab Arthritis RheumatoidArthritis Juvenile RheumatoidPsoriasisArthritis PsoriaticSpondylitis AnkylosingUveitisHidradenitis SuppurativaColitis UlcerativeCrohn Disease Date of authorisation...